Asia Insurance Post
  • Home
  • Articles
  • Blog
  • Data
  • Facts
  • Editorial
  • Interviews
Select Page

Insurance regulators tightening rules for asset-intensive reinsurance, promote alternative forms of insurance risk transfer

by AIP Online Bureau | Oct 15, 2026 | Eco/Invest/Demography, International News, Non-Life, Reinsurance | 0 comments

Regulatory bodies in Singapore, Hong Kong and the UK have launched consultations to introduce innovative risk transfer solutions built on protected cell companies. They aim to improve access to insurance covers for SMEs and to better spread peak natural catastrophe exposures.

Stockholm/Frankfurt: Insurance regulators are tightening rules for asset-intensive reinsurance while promoting alternative forms of insurance risk transfer, Fitch Ratings said in its latest update on global insurance regulatory developments, which covers April to September 2026.

The US National Association of Insurance Commissioners (NAIC) intends to revise the risk-based capital treatment of recapture risk related to asset-intensive reinsurance agreements outside of reciprocal jurisdictions. In response, the Cayman Islands has applied for Qualified Jurisdiction Status with the NAIC.

Meanwhile, the UK’s Prudential Regulatory Authority proposes to increase the counterparty default adjustment for funded reinsurance treaties.

Regulatory bodies in Singapore, Hong Kong and the UK have launched consultations to introduce innovative risk transfer solutions built on protected cell companies. They aim to improve access to insurance covers for SMEs and to better spread peak natural catastrophe exposures.

Submit a Comment Cancel reply

Your email address will not be published. Required fields are marked *

Recent Posts

  • IOC to buy crude, LPG ships as West Asia crisis exposes shipping risks
  • Building a Shock-Resilient Supply Chain: New Risk-Management Strategies
  • Medical tourism to India could spike if global insurance firms cover treatments: Sangita Reddy
  • Revised prices of 137 anti-cancer drugs to be effective from Nov 9, expected to result in annual savings of ₹3,500 crore
  • (no title)

Categories

  • Articles
  • Banking & Bancassurance
  • Blog
  • Breaking News!
  • Briefs
  • Climate, Environment, Renewable Energy
  • Data
  • Disaster & Management
  • Eco/Invest/Demography
  • Editorial
  • Events
  • Facts
  • Features
  • Health
  • Indian News
  • Intermediaries
  • International News
  • Interviews
  • Life
  • Main Menu
  • Non-Life
  • Pandemic
  • Pension & Social Security
  • Policy
  • Regulation
  • Reinsurance
  • Risk Management
  • Simple
  • Technology
  • Trends, Facts
  • Uncategorized
  • Wealth Management/ Philanthropy
  • Workplace/Employee Benefits
  • Home
  • Articles
  • Blog
  • Data
  • Facts
  • Editorial
  • Interviews
  • Eco/Invest/Demography
  • Indian News
  • International News
  • Health
  • Non-Life
  • Pandemic
  • Technology
  • Risk Management
  • Reinsurance
  • Banking & Bancassurance
  • Wealth Management/ Philanthropy